Lung fluid study for sarcoma patients having surgery
Part of Cancer clinical trials.
This study looks at fluid from the lungs of people with soft tissue sarcoma who are having surgery to remove a lung tumor. Researchers hope these samples can help understand the disease better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with soft tissue sarcoma
- You are planning to have surgery to remove a lung tumor as part of your usual care
- You have not had another cancer (except non-melanoma skin cancer) that was treated less than 2 years ago, or you have no history of other cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a special medication (5-ALA) before surgery makes the sarcoma glow under a special light, helping the surgeon see and remove the cancer more completely. The goal is to reduce the chance of leaving any cancer behind.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
This early-phase study tests a special way to deliver medicine directly to the lungs (called IVLP) for sarcoma that has spread to both lungs. It aims to control lung metastases while reducing side effects, and it uses a plan that often includes surgery or focused radiation around the procedure.
This study uses a special blood test to look for tiny traces of lung cancer after surgery. It aims to find “minimal residual disease,” meaning cancer cells that may still be hiding after your tumor is removed.
This study is testing a new blood test that looks for circulating tumor cells in your blood. The goal is to see if this test can help doctors make better treatment decisions for soft tissue sarcoma, potentially improving how the disease is managed.
Hear when a new Soft Tissue Sarcoma (STS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.